PATENT CLAIM ANALYSIS

Application Number: 15939837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
This invention relates to the use of combinations of stereoisomers of dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 5):
A pharmaceutical combination according to  claim 1  which comprises from 35 to 75 parts by weight of (+)-\u03b2-dihydrotetrabenazine and from 25 to 55 parts by weight of an \u03b1-dihydrotetrabenazine consisting of either (+)-\u03b1-dihydrotetrabenazine or (\u2212)-\u03b1-dihydrotetrabenazine or a mixture thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15939826', '12555695', '15044655', '15071797', '14030322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816243229611708
- 35 USC 102 Novelty (BERT): 0.6124967177012823
- Combined Prediction Score: 0.7647115624351819
- Mean Citation Score: 358.154622
- Max Citation Score: 664.932
- Similarity Product: 449.1569127645493

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test